Creative Medical Technology Holdings Inc. (CELZ) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Creative Medical Technology Holdings Inc. (CELZ:NASDAQ), powered by AI.

Current Price
$2.17
Sector
Healthcare
What is the Creative Medical Technology Holdings Inc. stock price forecast?

Creative Medical Technology Holdings Inc. is currently trading at $2.17. View real-time AI analysis on Alpha Lenz.

What is Creative Medical Technology Holdings Inc. insider trading activity?

View the latest insider trading data for Creative Medical Technology Holdings Inc. on Alpha Lenz.

What is Creative Medical Technology Holdings Inc.'s P/E ratio?

View Creative Medical Technology Holdings Inc.'s valuation metrics on Alpha Lenz.

Creative Medical Technology Holdings Inc.

NASDAQ · CELZ
$2.17+0.04(+1.88%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Creative Medical Technology Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Creative Medical Technology Holdings Inc.'s ROE is -86.5%. Explore profitability and growth together.

Ask for details

Company Overview

Creative Medical Technology Holdings Inc. is a biotechnology company dedicated to advancing regenerative medicine and immune-based therapies. The company's primary focus is on developing therapeutic solutions that address significant unmet medical needs, especially in the fields of immunology, hematology, and neurology. Creative Medical Technology Holdings Inc. leverages cutting-edge research in stem cell technology and uses it to develop innovative treatments that have the potential to revolutionize patient care across multiple medical disciplines. The company is active in pioneering treatments for degenerative diseases and aims to translate scientific advancements into clinical applications that improve patient outcomes. Creative Medical Technology Holdings Inc. plays a crucial role in the biotech sector by contributing to advancements in regenerative medicine, which is seen as a promising frontier for developing therapies that go beyond conventional medicine. As it continues its research and development activities, it holds a significant position within the healthcare and life sciences markets, impacting various industries devoted to improving human health and wellness.

CEOMr. Timothy Warbington
SectorHealthcare
IndustryBiotechnology
Employees4

Company Statistics

FY 2025

Profile

N/AMarket Cap
$6.00KRevenue
0.00Shares Out
4Employees

Margins

63.43%Gross
-100324.78%EBITDA
-102380.23%Operating
-99916.80%Pre-Tax
-99916.80%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-59.24%Rev 3Yr
-48.43%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-82.81%ROA
-86.53%ROE
-84.85%ROIC

Financial Health

$7.21MCash & Cash Equivalents
$-6.92MNet Debt
3.79%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Creative Medical Technology Holdings Inc. (ticker: CELZ) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 4 employees.

The current price is $2.17 with a P/E ratio of -x and P/B of -x.

ROE is -86.53% and operating margin is -102380.23%. Annual revenue is $6,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Creative Medical Technology Holdings Inc. (CELZ) Stock Forecast 2026 $2.17 — Price, Financials & Analyst Targets | Alpha Lenz